Investegate |Sensyne Health PLC Announcements | Sensyne Health PLC: Notice of Preliminary Results investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Oxford, U.K. 19 July 2021: Sensyne Health plc (LSE: SENS) ( Sensyne or the Company ), the ethical AI company, announces an update on its strategy which now includes exploring a potential dual-listing on Nasdaq amongst other options. As stated in our financial year end trading update on 27 May 2021, the Company continues to explore strategic opportunities, including making acquisitions, that leverage its organic growth and create additional shareholder value. Any decision to list in the US would complement the Company s primary listing on the AIM market of the London Stock Exchange and Sensyne remains committed to being a UK-headquartered company. Any acquisition or strategic equity partnership would
Investegate |Sensyne Health PLC Announcements | Sensyne Health PLC: NED Appointment investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Drayson Technologies Develops Next Generation Biometric Smart Cards Powered by Freevolt Energy Harvesting
Innovate UK funded project enabled Drayson Technologies to develop Plug-n-Play reference designs of its Freevolt radio frequency energy harvesting technology, delivering 3x more power for biometric smart card applications in secure access, cryptocurrency, healthcare and finance
Drayson Technologies today announces the completion its Smart Grant project, funded by Innovate UK, the UK s innovation agency. During the 6-month project, the business received over £112,000 of funding in order to develop Plug-n-Play reference designs of its Freevolt proprietary radio frequency (RF) energy harvesting technology for smart card applications in secure access, cryptocurrency, healthcare and finance.
Real world patient database and revenues rapidly growing Sensyne poised for accelerated international growth Oxford, U.K. 27 May 2021: Sensyne Health plc (LSE: SENS) ( Sensyne or the Company ), the Clinical AI company, today announces an update on trading for the financial year ended 30 April 2021 ( FY 2021 ), and an outlook statement. UPDATE ON TRADING · Robust financial performance: FY 2021 unaudited revenues of at least £9.0 million (FY 2020: £2.1 million audited). · Strong revenue growth driven by contracts with life sciences companies, with recognition of the majority of the £4.8 million minimum revenues from MagnifEye AI technology contract with Excalibur Health Services ( Excalibur ). · Cash and cash equivalents were £23.6 million (unaudited) and excludes receipt of majority of minimum revenue payments from the Excalibur contract (FY 2020: £31.7 million au